Cargando…
Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751048/ https://www.ncbi.nlm.nih.gov/pubmed/17094791 http://dx.doi.org/10.1186/cc5062 |
| _version_ | 1782131412837597184 |
|---|---|
| author | Williams, Mark D Janes, Jonathan M Nelson, David R |
| author_facet | Williams, Mark D Janes, Jonathan M Nelson, David R |
| author_sort | Williams, Mark D |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-1751048 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2006 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-17510482006-12-27 Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death Williams, Mark D Janes, Jonathan M Nelson, David R Crit Care Letter BioMed Central 2006 2006-10-30 /pmc/articles/PMC1751048/ /pubmed/17094791 http://dx.doi.org/10.1186/cc5062 Text en Copyright © 2006 BioMed Central Ltd |
| spellingShingle | Letter Williams, Mark D Janes, Jonathan M Nelson, David R Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death |
| title | Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death |
| title_full | Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death |
| title_fullStr | Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death |
| title_full_unstemmed | Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death |
| title_short | Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death |
| title_sort | drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751048/ https://www.ncbi.nlm.nih.gov/pubmed/17094791 http://dx.doi.org/10.1186/cc5062 |
| work_keys_str_mv | AT williamsmarkd drotrecoginalfaactivatedcurrentevidencesupportstreatmentforseveresepsispatientswithahighriskofdeath AT janesjonathanm drotrecoginalfaactivatedcurrentevidencesupportstreatmentforseveresepsispatientswithahighriskofdeath AT nelsondavidr drotrecoginalfaactivatedcurrentevidencesupportstreatmentforseveresepsispatientswithahighriskofdeath |